S

Stereotaxis Inc
F:RJR1

Watchlist Manager
Stereotaxis Inc
F:RJR1
Watchlist
Price: 0.671 EUR 9.64% Market Closed
Market Cap: €15.3m

Relative Value

RJR1 price has not been updated for more than 6 years. This may indicate that the stock has been delisted.
RJR1 doesn't have a meaningful market cap.

The Relative Value of one RJR1 stock under the Base Case scenario is 0.712 EUR. Compared to the current market price of 0.671 EUR, Stereotaxis Inc is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RJR1 Relative Value
Base Case
0.712 EUR
Undervaluation 6%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

RJR1 Competitors Multiples
Stereotaxis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Stereotaxis Inc
F:RJR1
171.6m EUR 5.3 -7.5 -8.4 -7.7
US
Abbott Laboratories
NYSE:ABT
180.7B USD 4.1 27.7 15.9 21.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.6B USD 16.6 58.7 44.5 54.7
US
Stryker Corp
NYSE:SYK
127.2B USD 5 38.7 19.8 24
IE
Medtronic PLC
NYSE:MDT
111.1B USD 3.1 24.1 13.3 19.4
US
Boston Scientific Corp
NYSE:BSX
101.1B USD 5 34.9 20.5 27.6
DE
Siemens Healthineers AG
XETRA:SHL
41.4B EUR 1.8 19.6 11 15.5
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 7.8 44.2 24.3 26.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD 10.6 42.9 30.4 33.7
US
Becton Dickinson and Co
NYSE:BDX
44.4B USD 2 25.3 10 16.9
US
Resmed Inc
NYSE:RMD
33.2B USD 6.2 22.4 15.7 17.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Stereotaxis Inc
F:RJR1
Average EV/EBITDA: 20.5
Negative Multiple: -8.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
15.9
11%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
44.5
23%
1.9
US
Stryker Corp
NYSE:SYK
19.8
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.3
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.5
18%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
11
10%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
24.3
14%
1.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.4
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10
1%
10
US
Resmed Inc
NYSE:RMD
15.7
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Stereotaxis Inc
F:RJR1
Average EV/EBIT: 25.8
Negative Multiple: -7.7
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.8
18%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
54.7
25%
2.2
US
Stryker Corp
NYSE:SYK
24
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.4
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
27.6
25%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
15.5
15%
1
US
Edwards Lifesciences Corp
NYSE:EW
26.6
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.7
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
16.9
15%
1.1
US
Resmed Inc
NYSE:RMD
17.5
12%
1.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett